BACKGROUND: Olfactory dysfunction (OD) is a common problem, affecting up to 20% of the general population. Previous studies identified olfactory cleft mucus proteins associated with OD in chronic rhinosinusitis (CRS) but not in a healthy population. In this study we aimed to identify olfactory cleft mucus proteins associated with olfaction in individuals without sinus disease. METHODS: Subjects free of sinus disease completed medical history questionnaires that collected data regarding demographics, comorbidities, and past exposures. Olfactory testing was performed using Sniffin' Sticks, evaluating threshold, discrimination, and identification. Olfactory cleft mucus (OC) and, in select cases, inferior turbinate mucus (IT) were collected with Leukosorb paper and assays performed for 17 proteins, including growth factors, cytokines/chemokines, cell-cycle regulators, and odorant-binding protein (OBP). RESULTS: Fifty-six subjects were enrolled in the study, with an average age of 47.8 (standard deviation [SD], 17.6) years, including 33 females (58.9%). The average threshold/discrimination/identification (TDI) score was 30.3 (SD, 6.4). In localization studies, OBP concentrations were significantly higher in OC than IT mucus (p = 0.006). Cyclin-dependent kinase inhibitor 2A (CDKN2A/p16INK4a), basic fibroblast growth factor (bFGF), chemokine ligand 2 (CCL2/MCP-1), granulocyte macrophage colony-stimulating factor (GM-CSF), and chemokine ligand 20 (CCL20/MIP-3a) all inversely correlated with overall TDI (all rho ≥ -0.479, p ≤ 0.004). Stem cell factor (SCF) correlated positively with overall TDI (rho = 0.510, p = 0.002). CONCLUSION: Placement of Leukosorb paper is relatively site-specific for olfactory proteins and it is feasible to collect a variety of olfactory cleft proteins that correlate with olfactory function. Further study is required to determine mechanisms of OD in non-CRS subjects.
BACKGROUND:Olfactory dysfunction (OD) is a common problem, affecting up to 20% of the general population. Previous studies identified olfactory cleft mucus proteins associated with OD in chronic rhinosinusitis (CRS) but not in a healthy population. In this study we aimed to identify olfactory cleft mucus proteins associated with olfaction in individuals without sinus disease. METHODS: Subjects free of sinus disease completed medical history questionnaires that collected data regarding demographics, comorbidities, and past exposures. Olfactory testing was performed using Sniffin' Sticks, evaluating threshold, discrimination, and identification. Olfactory cleft mucus (OC) and, in select cases, inferior turbinate mucus (IT) were collected with Leukosorb paper and assays performed for 17 proteins, including growth factors, cytokines/chemokines, cell-cycle regulators, and odorant-binding protein (OBP). RESULTS: Fifty-six subjects were enrolled in the study, with an average age of 47.8 (standard deviation [SD], 17.6) years, including 33 females (58.9%). The average threshold/discrimination/identification (TDI) score was 30.3 (SD, 6.4). In localization studies, OBP concentrations were significantly higher in OC than IT mucus (p = 0.006). Cyclin-dependent kinase inhibitor 2A (CDKN2A/p16INK4a), basic fibroblast growth factor (bFGF), chemokine ligand 2 (CCL2/MCP-1), granulocyte macrophage colony-stimulating factor (GM-CSF), and chemokine ligand 20 (CCL20/MIP-3a) all inversely correlated with overall TDI (all rho ≥ -0.479, p ≤ 0.004). Stem cell factor (SCF) correlated positively with overall TDI (rho = 0.510, p = 0.002). CONCLUSION: Placement of Leukosorb paper is relatively site-specific for olfactory proteins and it is feasible to collect a variety of olfactory cleft proteins that correlate with olfactory function. Further study is required to determine mechanisms of OD in non-CRS subjects.
Authors: Jennifer Lavin; Jin-Young Min; Alcina K Lidder; Julia He Huang; Atsushi Kato; Kent Lam; Eric Meen; Joan S Chmiel; James Norton; Lydia Suh; Mahboobeh Mahdavinia; Kathryn E Hulse; David B Conley; Rakesh K Chandra; Stephanie Shintani-Smith; Robert C Kern; Robert P Schleimer; Bruce K Tan Journal: Laryngoscope Date: 2017-03-21 Impact factor: 3.325
Authors: Taylor S Pence; Evan R Reiter; Laurence J DiNardo; Richard M Costanzo Journal: JAMA Otolaryngol Head Neck Surg Date: 2014-10 Impact factor: 6.223
Authors: Rodney J Schlosser; Jennifer K Mulligan; J Madison Hyer; Tom T Karnezis; David A Gudis; Zachary M Soler Journal: JAMA Otolaryngol Head Neck Surg Date: 2016-08-01 Impact factor: 6.223
Authors: Amanda Collins; Rachel A Bear; Amritha Mallikarjun; Sarah A Kane; Jennifer L Essler; Patricia Kaynaroglu; Rebecca Feuer; Jordan G Smith; Cynthia M Otto Journal: Front Vet Sci Date: 2022-05-18
Authors: Daniel M Beswick; Timothy L Smith; Jess C Mace; Jeremiah A Alt; Nyssa F Farrell; Vijay R Ramakrishnan; Rodney J Schlosser; Zachary M Soler Journal: Int Forum Allergy Rhinol Date: 2020-06-18 Impact factor: 3.858
Authors: Zachary M Soler; Rodney J Schlosser; Todd E Bodner; Jeremiah A Alt; Vijay R Ramakrishnan; Jose L Mattos; Jennifer K Mulligan; Jess C Mace; Timothy L Smith Journal: J Allergy Clin Immunol Date: 2021-02-04 Impact factor: 10.793
Authors: Aiko I Klingler; Whitney W Stevens; Bruce K Tan; Anju T Peters; Julie A Poposki; Leslie C Grammer; Kevin C Welch; Stephanie S Smith; David B Conley; Robert C Kern; Robert P Schleimer; Atsushi Kato Journal: J Allergy Clin Immunol Date: 2020-12-14 Impact factor: 10.793
Authors: Zachary M Soler; Rodney J Schlosser; Jennifer K Mulligan; Timothy L Smith; Jess C Mace; Vijay R Ramakrishan; Kim Norris-Caneda; Jennifer R Bethard; Lauren E Ball Journal: Int Forum Allergy Rhinol Date: 2020-12-04 Impact factor: 5.426
Authors: Timothy L Smith; Rodney J Schlosser; Zachary M Soler; Jess C Mace; Jose L Mattos; Vijay R Ramakrishnan; Daniel M Beswick; Jeremiah A Alt; Jennifer K Mulligan Journal: Int Forum Allergy Rhinol Date: 2021-02-24 Impact factor: 5.426